RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81 | +22.7% | 27 | 0.0% | 0.00% | – |
| Q2 2023 | $66 | -48.0% | 27 | -51.8% | 0.00% | – |
| Q1 2023 | $127 | -95.8% | 56 | -92.8% | 0.00% | – |
| Q4 2022 | $3,000 | -98.6% | 777 | -86.2% | 0.00% | – |
| Q3 2022 | $208,000 | +128.6% | 5,627 | +17.8% | 0.00% | – |
| Q2 2022 | $91,000 | +15.2% | 4,777 | +64.6% | 0.00% | – |
| Q1 2022 | $79,000 | +2533.3% | 2,902 | +2745.1% | 0.00% | – |
| Q4 2021 | $3,000 | -85.7% | 102 | -87.4% | 0.00% | – |
| Q3 2021 | $21,000 | +23.5% | 809 | +54.7% | 0.00% | – |
| Q2 2021 | $17,000 | +41.7% | 523 | +60.9% | 0.00% | – |
| Q1 2021 | $12,000 | +20.0% | 325 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | -16.7% | 325 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | +300.0% | 325 | +333.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |